Tag: Molnupiravir
Covid-19: Merck’s Molnupiravir antiviral drug recommended by WHO
News Published 21 hours ago, Reading 2 mins. in collaboration with Dr Gérald Kierzek (Medical Director of Doctissimo) The American laboratory Merck has obtained the recommendation of the World Health…
What treatments are available for Covid-19?
At the very beginning of the pandemic, only paracetamol was offered to patients with a mild to moderate form of SARS-CoV-2. Since then, research has made good progress and treatments…
What is molnupiravir? What is Molnupiravir used for? Who will use molnupiravir?
Molnupiravir drug and its side effects were discussed a lot with the start of the use of the drug in question. Approved for medical use in the UK in November…
Japan gives emergency use approval to coronavirus drug Molnupiravir
The Ministry of Health of Japan has given domestic use permission to the drug “Molnupiravir” to be used orally against Kovid-19. Accordingly, patients aged 18 years and older with mild…
Molnupiravir: dismissed by the HAS, return to the disappointments of the Merck pill
The High Authority for Health (HAS) has just pronounced on the use of Molnupiravir to fight against Covid-19. The effectiveness of the Merck pill is called into question by new…
Will anti-Covid-19 treatments create mutant viruses?
A prominent virologist warns against the use of molnupiravir, Merck’s anti-Covid pill, which has high mutagenic potential. The large-scale administration of this drug could promote the appearance of resistant viruses,…
The effectiveness of the coronavirus drug Molnupiravir fell from 50 percent to 30 percent
US pharmaceutical company Merck announced in the past weeks that it has developed the first pill form Molnupiravir, which reduces the effects of coronavirus and virus-related death rates, and stated…